Articles

The deal, which is set to close by the end of the first quarter of 2021, will provide Horizon with access to Viela’s rare disease medicine portfolio. 

Horizon Therapeutics to Acquire Viela Bio for $3 Billion

Nexelis’ recent acquisition of GSK’s Marburg, Germany-based vaccines clinical bioanalytical laboratory expands its bioanalytical capabilities.

Nexelis Expands Bioanalytical Services with Bioanalytical Lab Acquisition

The £500,000 (US$686,294)-investment in mass spectrometry support will accelerate biologics development and approval.

Almac Invests in Expanding Global Biologics Testing Solutions

Bayer will support CureVac by providing the company with further development, supply, and territory operations via its clinical operations, regulatory affairs, pharmacovigilance, medical information, and supply chain management expertise. 

Bayer to Manufacture CureVac’s COVID-19 Vaccine

The vaccine will be developed using Gritstone’s proprietary prime-boost vaccine platform, which includes self-amplifying mRNA and adenoviral vectors, with antigens formulated by Gilead.

Gilead and Gritstone Initiate $785 Million HIV Vaccine Collaboration

Cytiva acquired Vanrx Pharmasystems, a Canadian manufacturer of robotic aseptic filling equipment.

Cytiva Acquires Vanrx Pharmasystems

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

With Democrats controlling Congress and the White House, expectations are high that policy makers will revise certain coverage and payment policies. 

Will Democrats Squeeze Down Drug Prices?

The European Medicines Agency has recommended granting conditional marketing authorization for AstraZeneca’s COVID-19 vaccine.

European Medicines Agency Recommends AstraZeneca COVID-19 Vaccine for Authorization

FDA published guidance that includes risk-based recommendations for minimizing the potential transmission of COVID-19.

Manufacturing Considerations for Cell and Gene Therapies During COVID-19

A contract from the US government will help fund domestic US production of small-molecule APIs and finished dosage forms and will be the first GMP facility using ICM technology.

News